New hope to shield kidneys in sickle cell disease
NCT ID NCT07175051
Summary
This study is testing if a drug called empagliflozin can help protect the kidneys of people with sickle cell anemia. It will involve 20 adults who already show early signs of kidney damage. Researchers will measure changes in urine and blood tests, and use a special kidney scan, to see if the drug slows the progression of kidney disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALBUMINURIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Illinois Chicago, Sickle Cell Center
Chicago, Illinois, 60302, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.